India Exchange Filings

Health X Platform Board Meeting Highlights

Health X Platform Ltd approves Q2 FY27 results, with consolidated revenue of ₹484.09 crore and net loss of ₹12.73 crore

  • Revenue rose 8.3% sequentially and 60.7% year on year for the quarter ended 30 September 2026.
  • Net loss compared with a profit in Q1 FY27 and a loss of approximately ₹15.44 crore in Q2 FY26.
  • Limited-review conclusions were unmodified; the consolidated report flagged going-concern uncertainty at step-down subsidiary Genu Path Labs, whose net worth was fully eroded.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.